Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →Astral delivered a strong Q2 FY2026 with 20% volume growth and 15% value growth, driven by new plant ramp-ups (Hyderabad, Kanpur), improved product mix toward value-added items, and aggressive market share gains despite weak industry demand and volatile pol...
✓ Verified against BSE filing
Astral delivered a strong Q2 FY2026 with 20% volume growth and 15% value growth, driven by new plant ramp-ups (Hyderabad, Kanpur), improved product mix toward value-added items, and aggressive market share gains despite weak industry demand and volatile polymer prices. Consolidated EBITDA margin remained healthy at 15%-16%, supported by cost controls and higher contribution from CPVC and other specialty products. Management reiterated double-digit growth guidance for FY2026, with H2 expected to be stronger seasonally. The UK adhesives business is recovering, posting 5% revenue growth and improving EBITDA from -2% to 7.33%. The upcoming CPVC plant (by Sep 2026) and potential anti-dumping duty on PVC are key catalysts. Key risk: if ADD does not materialize, polymer prices may remain subdued, limiting value growth and margin expansion.
एस्ट्रल ने वित्त वर्ष 2026 की दूसरी तिमाही में शानदार प्रदर्शन किया। कंपनी ने बिक्री की मात्रा में 20% और कीमत के हिसाब से 15% बढ़ोतरी दर्ज की। यह हैदराबाद और कानपुर में नए कारखानों के चालू होने, ज्यादा मुनाफे वाले उत्पादों पर ध्यान देने और बाजार में हिस्सेदारी बढ़ाने से हुआ। यह तब भी हुआ जब उद्योग की मांग कमजोर थी और पॉलिमर की कीमतें उतार-चढ़ाव भरी थीं। कंपनी का मुनाफा (EBITDA) 15-16% रहा, जो लागत नियंत्रण और CPVC जैसे खास उत्पादों की बदौलत संभव हुआ। प्रबंधन ने पूरे साल दोहरे अंकों में वृद्धि का अनुमान दोहराया है। यूके का गोंद कारोबार सुधर रहा है, जहां बिक्री 5% बढ़ी और मुनाफा -2% से बढ़कर 7.33% हो गया। सितंबर 2026 तक नया CPVC प्लांट शुरू होगा और PVC पर आयात शुल्क लग सकता है। जोखिम: अगर शुल्क नहीं लगा तो पॉलिमर की कीमतें कम रह सकती हैं, जिससे वृद्धि सीमित होगी।
0 delivered, 0 close, 2 missed.
View Promises →Anti-dumping duty (ADD) on PVC may not be imposed
View Risks →Full transcript text is available on this route.
Read Transcript →Volume growth accelerated sharply from 0% in Q1 to 20% in Q2, driven by new plants and market share gains.
Improved from -2% in prior year, signaling turnaround under new CEO.
First time post-acquisition of Gem Paints, achieving near 20% growth in H1.
Channel inventory remains subdued due to PVC price volatility; potential restocking if ADD is imposed.
The UK business is expected to return to double-digit EBITDA margins by FY2027, with substantial improvement by March 2026.
Management guided that the paint segment will reach single-digit EBITDA margins by FY2027, up from current pressure.
Management reaffirmed guidance of double-digit volume growth for the full year, with H2 expected to be stronger than H1.
The 40,000 MTPA CPVC plant construction will start next month, with commissioning targeted by September 2026.
Bathware aims to sustain similar growth momentum in coming quarters, targeting 27% growth.
Paint business targets minimum 20% top-line growth for the full year, reaching around INR 240 crore run rate.
If the government does not impose ADD by the November 12 deadline, polymer prices may remain low, limiting value growth and margin expansion.
Hyderabad and Kanpur plants are running at 15-20% utilization, incurring losses; ramp-up may take longer if demand remains weak.
Opening nine new depots has increased employee and other costs, keeping paint margins under pressure; recovery may be slower than expected.
While EBITDA improved to 7.33%, the business is still below double-digit margins; new CEO transition and market conditions pose execution risk.
Q1 volumes were flat due to low demand, early monsoon, and low government spending. If demand does not revive post-festive season, growth targets may be missed.
EBITDA margin fell 211 bps YoY to 14.25% due to INR 25 crore inventory losses. Management indicated willingness to sacrifice 1-2% margin for volume growth, which could pressure profitability.
The CPVC resin plant uses in-house technology developed over three years. Scaling up from pilot to commercial production may face yield and stabilization challenges.
ROE has been declining due to high capex and slow utilization. New businesses like Bathware and Paint are still in investment phase, with Paint EBITDA margin at just 1.4%.
Mentioned in Q1 FY25, Q2 FY25, Q3 FY25, Q4 FY25
Capital expenditure for FY26 is guided at INR 250-300 crore, mainly for Kanpur plant completion and other expansions.
Mentioned in Q1 FY25, Q2 FY25
Management reiterated consolidated EBITDA margin guidance of 15-16%, with pipes at 16-18% and adhesives India at 15%.
Mentioned in Q1 FY25, Q4 FY25
Employee costs as a percentage of sales are higher than peers due to expansion in new businesses; attrition at 25% may indicate retention issues.
Mentioned in Q1 FY26, Q4 FY25
ROE has been declining due to high capex and slow utilization. New businesses like Bathware and Paint are still in investment phase, with Paint EBITDA margin at just 1.4%.
Management reaffirmed guidance of double-digit volume growth for the full year, with H2 expected to be stronger than H1.
If the government does not impose ADD by the November 12 deadline, polymer prices may remain low, limiting value growth and margin expansion.
View Risks →